Ceramide lipids, a known lipotoxic molecule among sphingolipids, can interfere with insulin signaling pathways and exacerbate hepatic and systemic insulin resistance, which is one of the primary drivers of non-alcoholic fatty liver disease (NAFLD) [49]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.